新型冠状病毒肺炎疫情前后我国4种肝炎发病趋势的时间序列分析
作者:
作者单位:

1.南京医科大学康达学院医学信息工程学部,江苏 连云港 222000 ;2.连云港市第一人民医院信息部,江苏 连云港 222000

中图分类号:

R512.6;R181.3

基金项目:

南京医科大学康达学院第二期品牌专业建设工程资助项目(JX206000302);南京医科大学康达学院医学信息模拟及预测科研团队资助项目(KD2022KYCXTD003)


Time series analysis of the incidence trend of four types of hepatitis in China before and after the COVID⁃19 pandemic
Author:
Affiliation:

1.Department of Medical Information Engineering,Kangda College,Nanjing Medical University,Lianyungang 222000 ;2.Information Department of the First People’s Hospital of Lianyungang City,Lianyungang 222000 ,China

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [25]
  • | | | |
  • 文章评论
    摘要:

    目的:探讨2019—2023年新型冠状病毒肺炎(coronavirus disease-2019,COVID-19)疫情前后我国4种肝炎(甲肝、乙肝、丙肝和戊肝)发病趋势的变化规律性,为疫情后肝炎防治提供参考依据。方法:通过我国2012—2023年4种肝炎时间序列的描述统计和季节性分解,对2019—2023年COVID-19疫情前后肝炎月发病数以及时间序列的长期趋势、季节因子和方差贡献率的动态变化进行比较和分析。结果:COVID-19疫情期间的2020—2022年,4种肝炎的平均月发病数低于疫情前的2019年,每种肝炎都出现2012年以来的历史最低值,疫情后的2023年月发病数都出现上升趋势。时间序列的分解表明,甲肝、乙肝、丙肝和戊肝,2012—2019 年与 2012—2023 年的季节因子高度相关,相关系数分别为 0.964、0.964、0.947 和 0.977(P 均< 0.001)。 2012—2019年、2012—2020年、2012—2021年、2012—2022年及2012—2023年4种肝炎的时间序列的方差呈上升趋势,长期趋势的方差贡献率呈上升趋势,与方差的相关系数分别为0.979、0.981、0.890和0.938(P均 < 0.05),季节因子的方差贡献率呈下降趋势,与方差的相关系数分别为 -0.978、-0.986、-0.954和 -0.936(P均 < 0.05)。结论:时间序列分解有助于研究肝炎长期趋势变化和周期性波动的规律性。甲肝和乙肝时间序列图的长期趋势变化特征明显,丙肝、戊肝时间序列图的周期性波动特征明显。疫情防控减少了4种肝炎的月发病数,对月发病数的长期趋势有较大影响,未改变发病低谷期和高峰期的周期性特征。面临疫情后肝炎发病数上升的挑战,要加强疫情后肝炎的监测工作,研究肝炎发病规律性,做好防控和治疗工作。

    Abstract:

    Objective:To explore the changing regularity of the incidence trend of four types of hepatitis(hepatitis A,hepatitis B, hepatitis C and hepatitis E)in China before and after the coronavirus disease-2019(COVID-19)pandemic between 2019 and 2023, and provide a reference for the prevention and treatment of hepatitis after the epidemic. Methods:Based on the descriptive statistics and seasonal decomposition of the four hepatitis time series between 2012 and 2023 in China,the monthly cases before and after the COVID-19 pandemic in 2019 and 2023 were compared and analyzed,as well as the long-term trend,seasonal factors and the dynamic change of variance contribution rate of the time series. Results:During the COVID-19 epidemic between 2020 and 2022,the average monthly cases of four types of hepatitis were lower than that in 2019 before the epidemic,each type of hepatitis had reached its lowest historical value since 2012,and the monthly cases of 2023 after the epidemic appeared an upward trend. The decomposition of time series showed that the seasonal factors of hepatitis A,B,C,and E in 2012- 2019 and 2012- 2023 were highly correlated,with correlation coefficients of 0.964,0.964,0.947,and 0.977,respectively(all P < 0.001). The variance of the time series of the four types of hepatitis of 2012-2019,2012-2020,2012-2021,2012-2022,2012-2023 showed an upward trend,the long-term trend variance contribution rates showed an upward trend,with correlation coefficients of 0.979,0.981,0.890,and 0.938 with variance,respectively (all P < 0.05),but the seasonal factor variance contribution rates showed a downward trend,with correlation coefficients of -0.978, -0.986,-0.954,and -0.936 with variance,respectively(all P < 0.05). Conclusion:The decomposition of the time series is helpful to study the regularity of the long -term trend changes and periodic fluctuation of hepatitis. The long -term trend is obvious for the time series diagram of hepatitis A or B,and the periodic fluctuation is obvious for the time series diagram of hepatitis C or E. The epidemic prevention and control have reduced the monthly cases of four types of hepatitis,which has a significant impact on the long-term trend of monthly cases but has not changed the cyclical characteristics of the low and peak periods of incidence. Faced with the challenge of an increase in the cases of hepatitis after the epidemic,it is necessary to strengthen the monitoring of hepatitis,explore the regularity of hepatitis incidence,and do a good job in prevention,control and treatment of hepatitis.

    参考文献
    [1] 杨瑞锋,陈红松.《2022—2030年全球卫生部门关于艾滋病、病毒性肝炎和性传播疾病行动计划》在病毒性肝炎领域的要求:解读及临床实践[J].中华检验医学杂志,2023,46(1):12-18.YANG R F,CHEN H S.Key points for viral hepatitis management in“Global health sector strategies on,respectively,HIV,viral hepatitis and sexually transmitted infections for the period 2022-2030”:interpretation and clinical practice[J].Chinese Journal of Laboratory Medicine,2023,46(1):12-18
    [2] 张翀,窦晓光.重视病毒性肝炎临床终点事件与疗效评价[J].中国实用内科杂志,2023,43(5):353-354.ZHANG C,DOU X G.Paying attention to clinical endpoint events of viral hepatitis and efficaly evaluation[J].Chinese Journal of Practical Internal Medicine,2023,43(5):353-354
    [3] 邵沛.积极预防主动检测规范治疗全面遏制肝炎危害——记2019年世界肝炎日宣传大会[J].中国社会组织,2019(15):33-35.SHAO P.Proactive prevention,proactive detection,standardized treatment,and comprehensive containment of hepatitis harm:the awareness conference on World Hepatitis Day 2019[J].China Social Organization,2019(15):33-35
    [4] 盛秋菊,窦晓光.乙肝患者早发现、早诊断、早治疗、早获益[J].肝博士,2022(3):1.SHENG Q J,DOU X G.Early detection,early diagnosis,early treatment and early benefit for hepatitis B patients[J].Liver Doctor,2022(3):1
    [5] CUCINOTTA D,VANELLI M.WHO declares COVID⁃19 a pandemic[J].Acta Biomed,2020,91(1):157-160
    [6] MAHASE E.Covid⁃19:WHO declares pandemic because of“alarming levels”of spread,severity,and inaction[J].BMJ,2020,368:m1036
    [7] 中华人民共和国国家卫生健康委员会.关于印发对新型冠状病毒感染实施“乙类乙管”总体方案的通知[EB/OL].(2022⁃12⁃26)[2024⁃08⁃01].http://www.nhc.gov.cn/xcs/zhengcwj/202212/e97e4c449d7a475794624b8ea12123c6.shtml.National Health Commission of the People’S Republic of China.Notice on the issuance of the plan for the implementation of treating the novel coronavirus infection as a category B disease[EB/OL].(2022⁃12⁃26)[2024⁃08⁃01].http://www.nhc.gov.cn/xcs/zhengcwj/202212/e97e4c449d7a475794624b8ea12123c6.shtml
    [8] 张翠玲,封婷,郑真真.新冠疫情以来中国的出生人口波动解析[J].人口与社会,2024,40(1):1-13.ZHANG C L,FENG T,ZHENG Z Z.An analysis of birth fluctuation in China since the COVID ⁃ 19 pandemic[J].Population and Society,2024,40(1):1-13
    [9] 王春荣.新冠疫情防控下手足口病肠道病毒的流行特征及变迁趋势[J].世界华人消化杂志,2024,32(4):254-260.WANG C R.Epidemic characteristics and changing trend of enterovirus infections in the context of prevention and control of COVID ⁃19 epidemic[J].World Chinese Journal of Digestology,2024,32(4):254-260
    [10] KE G B,HU Y,HUANG X,et al.Epidemiological analysis of hemorrhagic fever with renal syndrome in China with the seasonal⁃trend decomposition method and the exponential smoothing model[J].Sci Rep,2016,6:39350
    [11] 姚汶伶,马蒙蒙,刘艳慧,等.基于季节性分解在广州市 2015—2022年流感季节性及病原变迁分析中的应用[J].中国公共卫生,2023,39(7):823-829.YAO W L,MA M M,LIU Y H,et al.Seasonal characteristics and virus strain variation of influenza epidemics in Guangzhou city,2015-2022:seasonal-trend decomposition⁃based analysis[J].Chinese Journal of Public Health,2023,39(7):823-829
    [12] 马一鸣,丁勇.我国2012—2021年4种肝炎流行趋势的时间序列分析和预测[J].南京医科大学学报(自然科学版),2024,44(1):72-79.MA Y M,DING Y.Time series analysis and forecasting of four hepatitis epidemic trends in China from 2012 to 2021[J].Journal of Nanjing Medical University(Nature Sciences),2024,44(1):72-79
    [13] FENG L Z,ZHANG T,WANG Q,et al.Impact of COVID⁃ 19 outbreaks and interventions on influenza in China and the United States[J].Nat Commun,2021,12(1):3249
    [14] LAI S J,RUKTANONCHAI N W,CARIOLI A,et al.Assessing the effect of global travel and contact restrictions on mitigating the COVID ⁃19 pandemic[J].Engineering,2021,7(7):914-923
    [15] BRAUNER J M,MINDERMANN S,SHARMA M,et al.Inferring the effectiveness of government interventions against COVID ⁃ 19[J].Science,2021,371(6531):eabd9338
    [16] 李锋,魏莹.传染病扩散的对策及医疗资源配置问题研究——以新冠疫情为例[J].工业工程与管理,2024,29(2):114-129.LI F,WEI Y.The study of prevention strategies and healthcare resource allocation problem in COVID ⁃ 19 spreading scenarios[J].Industrial Engineering and Management,2024,29(2):114-129
    [17] 王栋,田勇泉,钱招昕,等.新冠肺炎疫情下跨区域医疗人力资源的应急调度研究[J].中国感染控制杂志,2021,20(8):742-747.WANG D,TIAN Y Q,QIAN Z X,et al.Emergency dispatching of trans⁃regional medical human resources under COVID ⁃ 19 epidemic[J].Chinese Journal of Infection Control,2021,20(8):742-747
    [18] World Health Organization.Global hepatitis report 2024:Action for access in low-and middle ⁃income countries[EB/OL].(2024 ⁃ 04 ⁃ 09)[2024 ⁃ 08 ⁃ 01].https://www.who.int/publications/i/item/9789240091672.
    [19] 庄辉.消除乙型肝炎进展[J].临床肝胆病杂志,2024,40(5):857-860.ZHUANG H.Progress towards elimination of hepatitis B[J].Journal of Clinical Hepatology,2024,40(5):857-860
    [20] US Center For Disease Control and Prevention.2023 viral hepatitis national progress report[EB/OL].(2023⁃08⁃08)[2024⁃08⁃01].https://www.cdc.gov/hepatitis/policy/npr/2023/index.htm.
    [21] COOKE G S,FLOWER B,CUNNINGHAM E,et al.Progress towards elimination of viral hepatitis:a lancet gastroenterology & hepatology commission update[J].Lancet Gastroenterol Hepatol,2024,9(4):346-365
    [22] World Health Organization.Global health sector strategy on viral hepatitis 2016⁃2021.Towards ending viral hepatitis[EB/OL].(2016⁃05⁃17)[2024⁃08⁃01].https://www.who.int/publications/i/item/WHO⁃HIV⁃2016.06
    [23] 吴晓宁,尤红,贾继东.迈向再无病毒性肝炎威胁的 2030[J].肝脏,2023,28(1):28-30.WU X N,YOU H,JIA J D.Towards 2030:no threat of viral hepatitis[J].Chinese Hepatology,2023,28(1):28-30
    [24] 崔富强,王富珍,郑徽,等.大力推动我国实现消除病毒性肝炎公共卫生威胁的目标[J].中华流行病学杂志,2021,42(9):1523-1526.CUI F Q,WANG F Z,ZHENG H,et al.Introduction of World Health Organization strategies and the technical advisory committee actions on viral hepatitis control and status of the elimination of viral hepatitis in China[J].Chinese Journal of Epidemiology,2021,42(9):1523-1526
    [25] World Health Organization.Global hepatitis report,2017[EB/OL].(2017 ⁃ 04 ⁃ 19)[2024 ⁃ 08 ⁃ 01].https://www.who.int/publications/item/9789241565455
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

陈静,瞿怀荣,赵巍,冯永华,丁勇.新型冠状病毒肺炎疫情前后我国4种肝炎发病趋势的时间序列分析[J].南京医科大学学报(自然科学版),2025,(3):334-345

复制
分享
文章指标
  • 点击次数:13
  • 下载次数: 21
  • HTML阅读次数: 6
  • 引用次数: 0
历史
  • 收稿日期:2024-08-15
  • 在线发布日期: 2025-03-17
关闭